Pharmaceutical and house building firms had a bad day of trading on the FTSE indices today, but the main index surprisingly pulled back some of the losses by close of business thanks to gains for Abbey and Centrica.
It was somewhat of a mixed day's trading as prices leapt up and down across the main indices. Both AstraZeneca and GlaxoSmithKline lost over 1.5% at the end of Friday trading, as a US consumer watchdog suggested AstraZeneca’s cholesterol drug was too dangerous to sell, and GSK received a ratings downgrade from Citigroup. The FTSE 100 eventually closed down just 0.2% to 4494.1 having earlier in the day lost another 10 points towards 4485 while the FTSE 250 index made a gain of 31.7 points or 0.5% to 6225.6 and the FTSE All-Share ended the day flat at 2238. Interest in the house build...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
